NextPlat (NXPL) Other Non Operating Income (2010 - 2025)
NextPlat's (NXPL) quarterly Other Non Operating Income came in at $5000.0 in Q4 2025, up 131.25% year-over-year from $2162.2 in Q4 2024, and up 150.0% quarter-over-quarter from -$10000.0 in Q3 2025.
Powered by 
Analysis
NextPlat (NXPL) Other Non Operating Income (2010 - 2025) Analysis & Trends
NextPlat (NXPL) has reported Other Non Operating Income for 15 consecutive years, with $5000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Other Non Operating Income rose 131.25% year-over-year to $5000.0 in Q4 2025; TTM through Dec 2025 was $206000.0, a 186.11% increase from a year earlier, with the FY2025 full-year figure at $206000.0, up 190.14% from the prior year.
- Other Non Operating Income was $5000.0 for Q4 2025 at NextPlat, up from -$10000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $266000.0 in Q2 2023 and troughed at -$165000.0 in Q3 2023.
- A 5-year average of $13253.9 and a median of -$1385.5 in 2021 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income sank 1700.0% in 2024 and soared 3100.0% in 2025, its largest moves.
- Over 5 years, Other Non Operating Income stood at -$3771.0 in 2021, then jumped by 2771.78% to $100753.0 in 2022, then tumbled by 99.01% to $1000.0 in 2023, then slumped by 1700.0% to -$16000.0 in 2024, then jumped by 131.25% to $5000.0 in 2025.
- The last three Other Non Operating Income figures came in at $5000.0 (Q4 2025), -$10000.0 (Q3 2025), and $150000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | -16,000.00 |
| Sep 30, 2024 | 119,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -165,000.00 |
| Jun 30, 2023 | 266,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 100,753.00 |
| Sep 30, 2022 | -89,025.00 |
| Jun 30, 2022 | -123,547.00 |
| Mar 31, 2022 | -17,181.00 |
| Dec 31, 2021 | -3,771.00 |
| Sep 30, 2021 | -69,464.00 |
| Jun 30, 2021 | 20,832.00 |
| Mar 31, 2021 | 16,481.00 |